• Home
  • keyboard_arrow_right Podcast
  • keyboard_arrow_right CEO Series
  • keyboard_arrow_rightPodcasts
  • keyboard_arrow_right
  • keyboard_arrow_right Gamechangers LIVE with David Ferrera, CEO of Quantum Fund


Gamechangers LIVE with David Ferrera, CEO of Quantum Fund

Sergio Tigera September 1, 2020

share close

Gamechangers LIVE with Special Guest David Ferrera, CEO of The Quantum Fund. David Ferrera is an engineer, entrepreneur, inventor and advisor with more than 25 years experience in the medical device field successfully developing products, founding companies, and managing them from concept through commercialization. He’s currently Chief Technology Officer of Balt which is dedicated to advancing therapies in hemorrhagic and ischemic stroke. David co-founded Blockade Medical in 2011 and was their President and CEO. Blockade was acquired by Balt Extrusion of France in August 2016. Balt designs, manufactures and distributes ‘Interventional Neuro Radiology’ (‘INR’) devices such as catheters, stents and coils that are essential in treating such conditions as hemorrhagic and ischemic stroke. Prior to co-founding Blockade he was co-founder and Vice President of Product Development/Clinical Research/General Manager of MindFrame Inc., of Irvine, CA. Mr. Ferrera formed and managed the team that successfully developed the company’s first acute stroke mechanical thrombectomy product line. MindFrame was acquired by Covidien/ev3 Neurovascular (now Medtronic Neurovascular) in 2012.

Previous episode